ArticleSpine deformity2025
Three-dimensional Rigo Cheneau-style brace for adolescent idiopathic scoliosis: higher in-brace correction and lower rates of curve progression.
Article in Spine deformity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Efficacy of a reduced brace wear regimen supported by Schroth exercise in adolescent idiopathic scoliosis: a randomized trial.Frontiers in pediatrics · 2026Trial
- Immediate in-brace correction and 1-year radiographic stability after a hybrid textile brace for adolescent idiopathic scoliosis: a retrospective cohort study.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026Article
- Bracing and non-surgical management of scoliosis in Canada: Early detection, access inequities, and the need for interdisciplinary reform.Canadian prosthetics & orthotics journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBracing has long been the mainstay of conservative management for adolescent idiopathic scoliosis (AIS) yet there is little data comparing treatment outcomes among different brace types. The purpose of this study is to compare curve progression and need for surgery between patients treated with Rigo Cheneau-style orthoses (RCSO) that focus on three-dimensional correction and traditional thoracolumbar-sacral orthoses (TLSO).
methodsPatients who began treatment at a single institution with an initial major coronal curve between 20° and 45° and no previous scoliosis treatment were included. Study endpoints were skeletal maturity or definitive fusion surgery. The outcome measures were percent curve correction in-brace, coronal curve progression at study endpoint, major coronal curve progression > 5°, major coronal curve progression > 10°, and progression to surgery.
results89 patients (47 RCSO and 42 TLSO) were included. Traditional TLSO patients had lower mean initial major curve compared to the RCSO cohort (30° vs. 33°, p = 0.021). TLSO patients had lower in-brace curve correction percent (22% vs. 48%, p < 0.001). Fifty-five percent of TLSO patients experienced curve progression of more than 5° compared to 30% of RCSO patients (p = 0.017). Forty-three percent of patients treated with TLSO experienced curve progression of more than 10° compared to only 13% of patients treated with RCSO (p = 0.001). By univariable analysis, there were no differences between TLSO and RCSO in risk of surgery recommended or performed (31% vs 30%, p = 0.905). However, the baseline predicted risk of progression ≥ 45° at initiation of bracing was lower in the TLSO cohort (49.1% vs. 61.5%, p = 0.079).
conclusionsPatients treated with RCSO have a higher in-brace curve correction and lower odds of curve progression compared to patients treated with TLSO.
Indexed as
Identifiers
40778973What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.